Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer (Q33482453)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 15 July 2009

Language	Label	Description	Also known as
English	Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer	scientific article published on 15 July 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

1 reference

based on heuristic

inferred from title

Aaron Mansfield

object named as

Aaron S Mansfield

1

0 references

author name string

Paivi S Heikkila

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Ari T Vaara

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Karl A J von Smitten

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Jukka M Vakkila

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Marjut H K Leidenius

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

15 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

231

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

15 July 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Mechanisms of local immunosuppression in cutaneous melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Prognostic factors in early breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

21 June 2018

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-231

21 January 2018

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-231

21 January 2018

Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-231

21 January 2018

Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-231

21 January 2018

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-231

21 January 2018

Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

31 October 2018

Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2723126

31 October 2018

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-231

21 January 2018

The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19604349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19604349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1 reference

https://pubmed.ncbi.nlm.nih.gov/19604349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/19604349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19604349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19604349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19604349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-9-231

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33482453&oldid=2195402098"